Bdh Industries Ltd vs Mangalam Drugs And Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of BDH Industries Ltd is ₹ 368 as of 05 May 15:30 . The P/E Ratio of BDH Industries Ltd is 0 as of March 2024 .The P/E Ratio of Mangalam Drugs and Organics Ltd is 0 as of March 2024 . The Market Cap of BDH Industries Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Mangalam Drugs and Organics Ltd is ₹ 146.65 crore as of March 2024 . The revenue of BDH Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Mangalam Drugs and Organics Ltd for the Dec '25 is ₹ 58.6 crore as compare to the Sep '25 revenue of ₹ 49.57 crore. This represent the growth of 18.22% The ebitda of BDH Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Mangalam Drugs and Organics Ltd for the Dec '25 is ₹ -1.32 crore as compare to the Sep '25 ebitda of ₹ -2.81 crore. This represent the decline of -53.02% The net profit of BDH Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 2.68 crore to ₹ -9.84 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of BDH Industries Ltd changed from 28.02 % on March 2021 to 27.96 % on March 2025 . This represents a CAGR of -0.04% over 5 yearsThe Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About BDH Industries Ltd

Incorporated in 1990 as a private limited company, BDH Industries Limited (BDHIL) was converted into a public limited company in 1994.
It was established to takeover a going concern, Bombay Drug House Pvt Ltd. This company was amalgamated with BDHIL in 1994 and, since then, it has been manufacturing a wide range of drug formulations in the antibiotic, anti-inflamatory and anti-microbial segments. The Company is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals and Renewable Energy segments.
BDH offers a full range of Oral Solid Dosages (OSD) technologies.
Research &Development Centre at Kandivali, Mumbai, undertake formulation development projects on new Novel Drug Delivery System (NDDS). It came out with a public issue in Feb.'95, aggregating Rs 6.

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
The company was promoted by Dhoot family.
The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

FAQs for the comparison of BDH Industries Ltd and Mangalam Drugs and Organics Ltd

Which company has a larger market capitalization, BDH Industries Ltd or Mangalam Drugs and Organics Ltd?

Market cap of BDH Industries Ltd is 217 Cr while Market cap of Mangalam Drugs and Organics Ltd is 48 Cr

What are the key factors driving the stock performance of BDH Industries Ltd and Mangalam Drugs and Organics Ltd?

The stock performance of BDH Industries Ltd and Mangalam Drugs and Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for BDH Industries Ltd and Mangalam Drugs and Organics Ltd?

As of May 5, 2026, the BDH Industries Ltd stock price is INR ₹378.0. On the other hand, Mangalam Drugs and Organics Ltd stock price is INR ₹30.66.

How do dividend payouts of BDH Industries Ltd and Mangalam Drugs and Organics Ltd compare?

To compare the dividend payouts of BDH Industries Ltd and Mangalam Drugs and Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.